Advertisement
UK markets closed

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.36
    +1.46 (+1.78%)
     

  • GOLD FUTURES

    2,336.20
    -10.20 (-0.43%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,249.88
    -186.59 (-0.35%)
     

  • CMC Crypto 200

    1,423.03
    +8.27 (+0.58%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Why Oncocyte Shot 13% Higher Today

Eric Volkman, The Motley Fool
·2-min read
Why Oncocyte Shot 13% Higher Today

Cancer diagnostics specialist Oncocyte (NYSEMKT: OCX) rose at a double-digit pace on Friday on news that it's tapping the stock market for a new round of capital-raising. Oncocyte priced its previously announced underwritten secondary stock issue of 7.78 million shares at $4.50 apiece. If all goes well, this should bring in gross proceeds of roughly $35 million.

Continue reading